NASDAQ:ONTX

Onconova Therapeutics Stock Insider Trading

etoro logo Buy ONTX
*Your capital is at risk
$24.16
+0.757 (+3.23%)
At Close: Jul 10, 2026

Onconova Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 3.03M and sold 52.77K ONTX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
0
Buy 3.03M shares
Sell 52.77K shares
86% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Dec 15, 2022
Buy
Common Stock
J-Other
Atadja Peter
Insider
Other 0
Value: $0
Aug 18, 2022
Buy
Stock Option (right to purchase)
A-Award
Stover Jack E
Director
Director 66 468
Value: $83.7K
Aug 18, 2022
Buy
Stock Option (right to purchase)
A-Award
Stover Jack E
Director 66 468
Value: $0
Aug 18, 2022
Buy
Stock Option (right to purchase)
A-Award
Marino James J
Director
Director 66 468
Value: $83.7K
Aug 18, 2022
Buy
Stock Option (right to purchase)
A-Award
Marino James J
Director 66 468
Value: $0
Aug 18, 2022
Buy
Stock Option (right to purchase)
A-Award
Mehta Viren
Director 66 468
Value: $0
Aug 18, 2022
Buy
Stock Option (right to purchase)
A-Award
Shoemaker Mary Teresa
Director 66 468
Value: $0
Aug 18, 2022
Buy
Stock Option (right to purchase)
A-Award
Groopman Jerome
Director
Director 66 468
Value: $83.7K
Aug 18, 2022
Buy
Stock Option (right to purchase)
A-Award
Groopman Jerome
Director 66 468
Value: $0
Aug 02, 2022
Buy
Common Stock
M-Exempt
Guerin Mark Patrick
CFO And COO
C-Suite Officer 4 750
Value: $0
Aug 02, 2022
Sell
Common Stock
F-InKind
Guerin Mark Patrick
CFO And COO
C-Suite Officer 1 355
Value: $2K
Aug 02, 2022
Buy
Restricted Stock Units
M-Exempt
Guerin Mark Patrick
CFO And COO
C-Suite Officer 4 750
Value: $0
Aug 02, 2022
Buy
Restricted Stock Units
M-Exempt
Gelder Mark S. Md
Chief Medical Officer
Officer 4 650
Value: $0
Aug 02, 2022
Buy
Common Stock
M-Exempt
Gelder Mark S. Md
Chief Medical Officer
Officer 4 650
Value: $0
Aug 02, 2022
Sell
Common Stock
F-InKind
Gelder Mark S. Md
Chief Medical Officer
Officer 1 135
Value: $1K
Aug 02, 2022
Buy
Common Stock
M-Exempt
Fruchtman Steven M
President, Chief Executive Off
CEO / President 12 566
Value: $0
Aug 02, 2022
Sell
Common Stock
F-InKind
Fruchtman Steven M
President, Chief Executive Off
CEO / President 4 562
Value: $6K
Aug 02, 2022
Buy
Restricted Stock Units
M-Exempt
Fruchtman Steven M
President, Chief Executive Off
CEO / President 12 566
Value: $0
Jun 10, 2022
Buy
Stock Option (right to purchase)
A-Award
Guerin Mark Patrick
COO And CFO
C-Suite Officer 50 250
Value: $0
Jun 10, 2022
Buy
Stock Option (right to purchase)
A-Award
Guerin Mark Patrick
COO And CFO
C-Suite Officer 50 250
Value: $66.8K
Jun 10, 2022
Buy
Restricted Stock Units
A-Award
Guerin Mark Patrick
COO And CFO
C-Suite Officer 16 500
Value: $0
Feb 07, 2022
Buy
Stock Option (right to purchase)
A-Award
Gelder Mark S. Md
Chief Medical Officer
Officer 51 750
Value: $94.2K
Feb 07, 2022
Buy
Restricted Stock Units
A-Award
Gelder Mark S. Md
Chief Medical Officer
Officer 17 500
Value: $0
Feb 07, 2022
Buy
Stock Option (right to purchase)
A-Award
Fruchtman Steven M
President, Chief Executive Off
CEO / President 191 880
Value: $349.2K
Feb 07, 2022
Buy
Restricted Stock Units
A-Award
Fruchtman Steven M
President, Chief Executive Off
CEO / President 63 960
Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT ONCONOVA THERAPEUTICS INC
Onconova Therapeutics
Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. It has two clinical-stage programs, including narazaciclib (ON 123300), a multi-targeted kinase inhibitor that is in Phase I study for solid tumors, as well as hematological malignancies as a single agent or in combination with other anti-cancer therapies; and oral rigosertib alone or in combination with P...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
11.34% Jun 29
NMRK
$15.02
1.20% Jun 24
NESR
$25.07
14.16% Jun 23
CAG
$13.43
2.98% Jun 23
GIB
$66.69
0.555% Jun 12

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE